Please use this identifier to cite or link to this item:
Title: Assessment of different strategies for scalable production and proliferation of human myoblasts
Authors: Chua, M.-W.J.
Yildirim, E.D.
Tan, J.-H.E. 
Chua, Y.-J.B. 
Low, S.-M.C.
Ding, S.L.S.
Li, C.-W.
Jiang, Z.
Teh, B.T. 
Yu, K.
Shyh-Chang, N.
Keywords: adult stem cells
cell fate
cellular differentiation
embryonic stem cells
musculoskeletal system
Issue Date: 2019
Publisher: Blackwell Publishing Ltd
Citation: Chua, M.-W.J., Yildirim, E.D., Tan, J.-H.E., Chua, Y.-J.B., Low, S.-M.C., Ding, S.L.S., Li, C.-W., Jiang, Z., Teh, B.T., Yu, K., Shyh-Chang, N. (2019). Assessment of different strategies for scalable production and proliferation of human myoblasts. Cell Proliferation 52 (3) : e12602. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Objectives: Myoblast transfer therapy (MTT) is a technique to replace muscle satellite cells with genetically repaired or healthy myoblasts, to treat muscular dystrophies. However, clinical trials with human myoblasts were ineffective, showing almost no benefit with MTT. One important obstacle is the rapid senescence of human myoblasts. The main purpose of our study was to compare the various methods for scalable generation of proliferative human myoblasts. Methods: We compared the immortalization of primary myoblasts with hTERT, cyclin D1 and CDK4R24C, two chemically defined methods for deriving myoblasts from pluripotent human embryonic stem cells (hESCs), and introduction of viral MyoD into hESC-myoblasts. Results: Our results show that, while all the strategies above are suboptimal at generating bona fide human myoblasts that can both proliferate and differentiate robustly, chemically defined hESC-monolayer-myoblasts show the most promise in differentiation potential. Conclusions: Further efforts to optimize the chemically defined differentiation of hESC-monolayer-myoblasts would be the most promising strategy for the scalable generation of human myoblasts, for applications in MTT and high-throughput drug screening. © 2019 John Wiley & Sons Ltd
Source Title: Cell Proliferation
ISSN: 09607722
DOI: 10.1111/cpr.12602
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1111_cpr_12602.pdf2.69 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons